Floatz logo

Florbetaben

Spinocerebellar Ataxias (SCA)

University of MinnesotaSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Spinocerebellar Ataxias (SCA) cohort.

Asset / SponsorPhaseRating
Riluzole
S. Andrea Hospital
Phase 2/3BB

Same molecule, other indications

Florbetaben is also rated in:

Cardiac AmyloidosisDormant
BBB
Indicative ·
73 / 100
View asset →
Alzheimer diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
Amyloid Beta-ProteinDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →